ABEIXI™
生化试剂
| SP-MHCI-0894-2 | Human Telomerase reverse transcriptase 865-873, RLVDDFLLV |
| SP-MHCI-0894-3 | Human Telomerase reverse transcriptase 865-873, RLVDDFLLV |
| SP-MHCI-0895-2 | Human Cyclin-A1 385-395, SLIAAAAFCLA |
| SP-MHCI-0895-3 | Human Cyclin-A1 385-395, SLIAAAAFCLA |
| SP-MHCI-0896-2 | Human MAGE 1 112-126, FLLLKYRAREPVTKAE |
| SP-MHCI-0896-3 | Human MAGE 1 112-126, FLLLKYRAREPVTKAE |
| SP-MHCI-0897-2 | Human GTPase KRas 5-13, KLVVVGACGV |
| SP-MHCI-0897-3 | Human GTPase KRas 5-13, KLVVVGACGV |
| SP-MHCI-0898-2 | Human Prostate stem cell antigen 96-104, AILALLPAL |
| SP-MHCI-0898-3 | Human Prostate stem cell antigen 96-104, AILALLPAL |
| SP-MHCI-0899-2 | Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL |
| SP-MHCI-0899-3 | Human RalBP1-associated Eps domain-containing protein 1 42-50, AQLANDVVL |
| SP-MHCI-0900-2 | Human Glutamate carboxypeptidase 2 4-12, LLHETDSAV |
| SP-MHCI-0900-3 | Human Glutamate carboxypeptidase 2 4-12, LLHETDSAV |
| SP-MHCI-0901-2 | Survivin (BIRC5) 97-111, TLGEFLKLDRERAKN |
| SP-MHCI-0901-3 | Survivin (BIRC5) 97-111, TLGEFLKLDRERAKN |
| SP-MHCI-0902-2 | Human GTPase KRas 10-18, GADGVGKSA |
| SP-MHCI-0902-3 | Human GTPase KRas 10-18, GADGVGKSA |
| SP-MHCI-0903-2 | Human GTPase KRas 10-19, GADGVGKSAL |
| SP-MHCI-0903-3 | Human GTPase KRas 10-19, GADGVGKSAL |
| SP-MHCI-0904-2 | Human GTPase KRas 10-18, GAGGVGKSA |
| SP-MHCI-0904-3 | Human GTPase KRas 10-18, GAGGVGKSA |
| SP-MHCI-0905-2 | Human GTPase KRas 10-19, GAGGVGKSAL |
| SP-MHCI-0905-3 | Human GTPase KRas 10-19, GAGGVGKSAL |
| SP-MHCI-0906-2 | Human Chromogranin-A 358-376, LEGQEEEEDNRDSSMKLSF |
| SP-MHCI-0906-3 | Human Chromogranin-A 358-376, LEGQEEEEDNRDSSMKLSF |
| SP-MHCI-0907-2 | Human GTPase KRas 7-16, VVVGAGGVGK |
| SP-MHCI-0907-3 | Human GTPase KRas 7-16, VVVGAGGVGK |
| SP-MHCI-0908-2 | SARS-CoV-2 Spike 166-180, CTFEYVSQPFLMDLE |
| SP-MHCI-0908-3 | SARS-CoV-2 Spike 166-180, CTFEYVSQPFLMDLE |
| SP-MHCI-0909-2 | SARS-CoV-2 ORF3a protein 207-215, FTSDYYQLY |
| SP-MHCI-0909-3 | SARS-CoV-2 ORF3a protein 207-215, FTSDYYQLY |
| SP-MHCI-0910-2 | SARS-CoV-2 Replicase polyprotein 1ab 2332-2340, ILFTRFFYV |
| SP-MHCI-0910-3 | SARS-CoV-2 Replicase polyprotein 1ab 2332-2340, ILFTRFFYV |
| SP-MHCI-0911-2 | SARS-CoV-2 Membrane protein 15-23, KLLEQWNLV |
| SP-MHCI-0911-3 | SARS-CoV-2 Membrane protein 15-23, KLLEQWNLV |
| SP-MHCI-0912-2 | SARS-CoV-2 Spike 801-815, NFSQILPDPSKPSKR |
| SP-MHCI-0912-3 | SARS-CoV-2 Spike 801-815, NFSQILPDPSKPSKR |
| SP-MHCI-0913-2 | SARS-CoV-2 Nucleoprotein 9-17, QRNAPRITF |
| SP-MHCI-0913-3 | SARS-CoV-2 Nucleoprotein 9-17, QRNAPRITF |
| SP-MHCI-0914-2 | SARS-CoV-2 Spike 866-880, TDEMIAQYTSALLAG |
| SP-MHCI-0914-3 | SARS-CoV-2 Spike 866-880, TDEMIAQYTSALLAG |
| SP-MHCI-0915-2 | SARS-CoV-2 Spike 269-277, YLQPRTFLL |
| SP-MHCI-0915-3 | SARS-CoV-2 Spike 269-277, YLQPRTFLL |
| SP-MHCI-0916-2 | Human GTPase KRas 7-15, VVVGADGVGK |
| SP-MHCI-0916-3 | Human GTPase KRas 7-15, VVVGADGVGK |
| SP-MHCI-0917-2 | Human GTPase KRas 7-15, VVVGAVGVGK |
| SP-MHCI-0917-3 | Human GTPase KRas 7-15, VVVGAVGVGK |
| SP-MHCI-0918-2 | Alphapolyomavirus quintihominis Large T antigen 99-107, FSFGKAYEY |
| SP-MHCI-0918-3 | Alphapolyomavirus quintihominis Large T antigen 99-107, FSFGKAYEY |
| SP-MHCI-0919-2 | Human TGF-beta receptor type-2 131-139, RLSSCVPVA |
| SP-MHCI-0919-3 | Human TGF-beta receptor type-2 131-139, RLSSCVPVA |
| SP-MHCI-0920-2 | Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK |
| SP-MHCI-0920-3 | Alphapolyomavirus quintihominis Large T antigen 95-103, RSGGFSFGK |
| SP-MHCI-0921-2 | Human core protein II precursor 22-31, SYMAPSTVL |
| SP-MHCI-0921-3 | Human core protein II precursor 22-31, SYMAPSTVL |
| SP-MHCI-0922-2 | Human GTPase KRas 8-16, VVGACGVGK |
| SP-MHCI-0922-3 | Human GTPase KRas 8-16, VVGACGVGK |
| SP-MHCI-0923-2 | Human GTPase KRas 8-16, VVGADGVGK |
| SP-MHCI-0923-3 | Human GTPase KRas 8-16, VVGADGVGK |
| SP-MHCI-0924-2 | Human GTPase KRas 7-16, VVVGACGVGK |
| SP-MHCI-0924-3 | Human GTPase KRas 7-16, VVVGACGVGK |
| SP-MHCI-0925-2 | SARS-CoV-2Nucleoprotein 311-325, ASAFFGMSRIGMEVT |
| SP-MHCI-0925-3 | SARS-CoV-2Nucleoprotein 311-325, ASAFFGMSRIGMEVT |
| SP-MHCI-0926-2 | SARS-CoV-2 Nucleoprotein 50-64, ASWFTALTQHGKEDL |
| SP-MHCI-0926-3 | SARS-CoV-2 Nucleoprotein 50-64, ASWFTALTQHGKEDL |
| SP-MHCI-0927-2 | SARS-CoV-2 Spike 131-145, CEFQFCNDPFLGVYY |
| SP-MHCI-0927-3 | SARS-CoV-2 Spike 131-145, CEFQFCNDPFLGVYY |
| SP-MHCI-0928-2 | SARS-CoV-2 Nucleoprotein 346-360, FKDQVILLNKHIDAY |
| SP-MHCI-0928-3 | SARS-CoV-2 Nucleoprotein 346-360, FKDQVILLNKHIDAY |
| SP-MHCI-0929-2 | SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA |
| SP-MHCI-0929-3 | SARS-CoV-2 ORF8 protein 41-55, FYSKWYIRVGARKSA |
| SP-MHCI-0930-2 | SARS-CoV-2 VEMP 56-70, FYVYSRVKNLNSSRV |
| SP-MHCI-0930-3 | SARS-CoV-2 VEMP 56-70, FYVYSRVKNLNSSRV |
| SP-MHCI-0931-2 | SARS-CoV-2 Nucleoprotein 328-342, GTWLTYTGAIKLDDK |
| SP-MHCI-0931-3 | SARS-CoV-2 Nucleoprotein 328-342, GTWLTYTGAIKLDDK |
| SP-MHCI-0932-2 | SARS-CoV-2 Spike 1101-1115, HWFVTQRNFYEPQII |
| SP-MHCI-0932-3 | SARS-CoV-2 Spike 1101-1115, HWFVTQRNFYEPQII |
| SP-MHCI-0933-2 | SARS-CoV-2 Replicase polyprotein 1ab 6219-6228, IEYPIIGDEL |
| SP-MHCI-0933-3 | SARS-CoV-2 Replicase polyprotein 1ab 6219-6228, IEYPIIGDEL |
| SP-MHCI-0934-2 | SARS-CoV-2 Nucleoprotein 84-98, IGYYRRATRRIRGGD |
| SP-MHCI-0934-3 | SARS-CoV-2 Nucleoprotein 84-98, IGYYRRATRRIRGGD |
| SP-MHCI-0935-2 | SARS-CoV-2 Spike 235-249, ITRFQTLLALHRSYL |
| SP-MHCI-0935-3 | SARS-CoV-2 Spike 235-249, ITRFQTLLALHRSYL |
| SP-MHCI-0936-2 | SARS-CoV-2 Nucleoprotein 127-141, KDGIIWVATEGALNT |
| SP-MHCI-0936-3 | SARS-CoV-2 Nucleoprotein 127-141, KDGIIWVATEGALNT |
| SP-MHCI-0937-2 | SARS-CoV-2 Membrane protein 165-178, KEITVATSRTLSYYK |
| SP-MHCI-0937-3 | SARS-CoV-2 Membrane protein 165-178, KEITVATSRTLSYYK |
| SP-MHCI-0938-2 | SARS-CoV-2 Nucleoprotein 221-235, LLLLDRLNQLESKMS |
| SP-MHCI-0938-3 | SARS-CoV-2 Nucleoprotein 221-235, LLLLDRLNQLESKMS |
| SP-MHCI-0939-2 | SARS-CoV-2 Membrane protein 176-190, LSYYKLGASQRVAGD |
| SP-MHCI-0939-3 | SARS-CoV-2 Membrane protein 176-190, LSYYKLGASQRVAGD |
| SP-MHCI-0940-2 | SARS-CoV-2 Spike 865-873, LTDEMIAQY |
| SP-MHCI-0940-3 | SARS-CoV-2 Spike 865-873, LTDEMIAQY |
| SP-MHCI-0941-2 | SARS-CoV-2 Spike 196-210, NIDGYFKIYSKHTPI |
| SP-MHCI-0941-3 | SARS-CoV-2 Spike 196-210, NIDGYFKIYSKHTPI |
| SP-MHCI-0942-2 | SARS-CoV-2 Nucleoprotein 326-340, PSGTWLTYTGAIKLD |
| SP-MHCI-0942-3 | SARS-CoV-2 Nucleoprotein 326-340, PSGTWLTYTGAIKLD |
| SP-MHCI-0943-2 | SARS-CoV-2 Spike 1208-1216, QYIKWPWYI |
| SP-MHCI-0943-3 | SARS-CoV-2 Spike 1208-1216, QYIKWPWYI |